Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Karakantza

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Clinical Pathology|March 1, 1996
Association between sarcoidosis and lymphoma revisitedM Karakantza, E Matutes, K MacLennan, et al.
Clinical and Experimental Immunology|April 22, 2008
T helper 1 (Th1)/Th2 cytokine expression shift of peripheral blood CD4+ and CD8+ T cells in patients at the post-acute phase of strokeG L Theodorou, S Marousi, J Ellul, et al.
Clinical and Experimental Immunology|August 30, 2008
Prognostic value of phagocytic activity of neutrophils and monocytes in sepsis. Correlation to CD64 and CD14 antigen expressionD D Danikas, M Karakantza, G L Theodorou, et al.
Clinical and Experimental Immunology|October 11, 2007
Effect of non-operative management (NOM) of splenic rupture versus splenectomy on the distribution of peripheral blood lymphocyte populations and cytokine production by T cellsG L Theodorou, A Mouzaki, D Tsiftsis, et al.
British Journal of Haematology|April 1, 1994
SLe(x) expression of normal CD34 positive bone marrow haemopoietic progenitor cellsM Karakantza, F M Gibson, J D Cavenagh, et al.
Transfusion Medicine (Oxford, England)|April 11, 2008
Procleix Ultrio transcription-mediated amplification vs. serological blood screening in south-western GreeceA Sgourou, M Karakantza, E Theodori, et al.
Leukemia|July 25, 2008
c-Jun N-terminal kinase activation failure is a new mechanism of anthracycline resistance in acute myeloid leukemiaE D Lagadinou, P G Ziros, O A Tsopra, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Clinical Pathology|March 1, 1996
Association between sarcoidosis and lymphoma revisitedM Karakantza, E Matutes, K MacLennan, et al.
Clinical and Experimental Immunology|April 22, 2008
T helper 1 (Th1)/Th2 cytokine expression shift of peripheral blood CD4+ and CD8+ T cells in patients at the post-acute phase of strokeG L Theodorou, S Marousi, J Ellul, et al.
Clinical and Experimental Immunology|August 30, 2008
Prognostic value of phagocytic activity of neutrophils and monocytes in sepsis. Correlation to CD64 and CD14 antigen expressionD D Danikas, M Karakantza, G L Theodorou, et al.
Clinical and Experimental Immunology|October 11, 2007
Effect of non-operative management (NOM) of splenic rupture versus splenectomy on the distribution of peripheral blood lymphocyte populations and cytokine production by T cellsG L Theodorou, A Mouzaki, D Tsiftsis, et al.
British Journal of Haematology|April 1, 1994
SLe(x) expression of normal CD34 positive bone marrow haemopoietic progenitor cellsM Karakantza, F M Gibson, J D Cavenagh, et al.
Transfusion Medicine (Oxford, England)|April 11, 2008
Procleix Ultrio transcription-mediated amplification vs. serological blood screening in south-western GreeceA Sgourou, M Karakantza, E Theodori, et al.
Leukemia|July 25, 2008
c-Jun N-terminal kinase activation failure is a new mechanism of anthracycline resistance in acute myeloid leukemiaE D Lagadinou, P G Ziros, O A Tsopra, et al.
Pageof 2